Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array

Oncology Reports

Volumn 16, Issue 3, 2006, Pages 587-595

  Hofmann, Hans Stefan ^a   Bartling, Babett ^a   Simm, Andreas ^a   Murray, Rich ^b   Aziz, Natasha ^b   Hansen, Gesine ^c   Silber, Rolf Edgar ^a   Burdach, Stefan ^d  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Bioinformatics Department   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

DNA array; Non small cell lung cancer

Indexed keywords

MACROPHAGE ELASTASE; METALLOPROTEINASE; MMP12 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN; UROKINASE;

AGED; ARTICLE; CELL CULTURE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 12; METALLOENDOPEPTIDASES; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; URINARY PLASMINOGEN ACTIVATOR;

EID: 33749189576     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.3.587     Document Type: Article

References (44)

1. Jemal A, Thomas A, Murray T and Thun M: Cancer statistics, 2002. CA Cancer J Clin 52: 23-47, 2002. (Pubitemid 34110469)
2. Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ and Sculier JP: Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J 18: 705-719, 2001. (Pubitemid 33040631)
3. Han H, Landreneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, Sturgis CD, Raab SS and Silverman JF: Prognostic value of immunohistochemical expressions of p53, HER-2/neu and bcl-2 in stage I non-small-cell lung cancer. Hum Pathol 33: 105-110, 2002. (Pubitemid 34112959)
4. Liao M, Wang H, Lin Z, Feng J and Zhu D: Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer. Lung Cancer 33: 125-132, 2001.
5. Shiba M, Kohno H, Kakizawa K, Iizasa T, Otsuji M, Saitoh Y, Hiroshima K, Ohwada H and Fujisawa T: Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected non-small cell lung carcinoma. Cancer 89: 1457-1465, 2000.
6. Martin B, Paesmans M, Berghmans T, Branle F, Ghisdal L, Mascaux C, Meert AP, Steels E, Vallot F, Verdebout JM, Lafitte JJ and Sculier JP: Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 89: 55-64, 2003. (Pubitemid 36897935)
7. Staege MS, Hattenhorst UE, Neumann UE, Hutter C, Foja S and Burdach S: DNA-microarrays as tools for the identification of tumor specific gene expression profiles: applications in tumor biology, diagnosis and therapy. Klin Padiatr 215: 135-139, 2003.
8. Travis W, Linder J and Mackay B: Classification, histology, cytology and electon microscopy. In: Lung Cancer: Principles and Practice. Pass H, Mitchel J, Johnson D and Turisi A (eds). Lippincott-Raven, Philadelphia, pp361-395, 1996.
9. Mountain C: Revision in the international system for staging lung cancer. Chest 111: 1170-1117, 1997.
10. Wodicka L, Dong H, Mittmann M, Ho MH and Lockhart DJ: Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol 15: 1359-1367, 1997. (Pubitemid 28022729)
11. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999.
12. Lipshutz RJ, Fodor SP, Gingeras TR and Lockhart DJ: High density synthetic oligonucleotide arrays. Nat Genet 21: 20-24, 1999. (Pubitemid 29031487)
13. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Rapp BA and Wheeler DL: GenBank. Nucleic Acids Res 28: 15-18, 2000. (Pubitemid 30047703)
14. Salamov AA and Solovyev VV: Ab initio gene finding in Drosophila genomic DNA. Genome Res 10: 516-522, 2000. (Pubitemid 30259081)
15. Ludwig JA and Weinstein JN: Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5: 845-856, 2005. (Pubitemid 41746029)
16. Staege MS, Hutter C, Neumann I, Foja S, Hattenhorst UE, Hansen G, Afar D and Burdach SE: DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 64: 8213-8221, 2004. (Pubitemid 39491758)
17. Staege MS, Hansen G, Baersch G and Burdach S: Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy. Pediatr Blood Cancer 43: 23-34, 2004. (Pubitemid 38738268)
18. Bartling B, Hofmann HS, Boettger T, Hansen G, Burdach S, Silber RE and Simm A: Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer 49: 145-154, 2005. (Pubitemid 40966741)
19. Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Catalona WJ, Watson MA and Milbrandt J: Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61: 5692-5696, 2001. (Pubitemid 32769078)
20. Van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536, 2002. (Pubitemid 34130608)
21. Inoue H, Matsuyama A, Mimori K, Ueo H and Mori M: Prognostic score of gastric cancer determined by cDNA microarray. Clin Cancer Res 8: 3475-3479, 2002. (Pubitemid 35340724)
22. Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, Ratschiller D, Gugger M, Donovan M, Lasek A and Rickert P: Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21: 7749-7763, 2002. (Pubitemid 35398821)
23. Bangur CS, Switzer A, Fan L, Marton MJ, Meyer MR and Wang T: Identification of genes overexpressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysis. Oncogene 21: 3814-3825, 2002. (Pubitemid 34620545)
24. Ju Z, Kapoor M, Newton K, Cheon K, Ramaswamy A, Lotan R, Strong LC and Koo JS: Global detection of molecular changes reveals concurrent alteration of several biological pathways in non-small cell lung cancer cells. Mol Genet Genomics: 1-14, 2005.
25. Kettunen E, Anttila S, Seppanen JK, Karjalainen A, Edgren H, Lindstrom I, Salovaara R, Nissen AM, Salo J, Mattson K, Hollmen J, Knuutila S and Wikman H: Differentially expressed genes in non-small cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet 149: 98-106, 2004. (Pubitemid 38293026)
26. Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M and Sommergruber W: Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 64: 844-856, 2004. (Pubitemid 38176883)
27. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK and Mao L: Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 60: 4000-4004, 2000. (Pubitemid 30636572)
28. Chen JJ, Peck K, Hong TM, Yang SC, Sher YP, Shih JY, Wu R, Cheng JL, Roffler SR, Wu CW and Yang PC: Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 61: 5223-5230, 2001. (Pubitemid 32681557)
29. Topcu Z: DNA topoisomerases as targets for anticancer drugs. J Clin Pharm Ther 26: 405-416, 2001.
30. Isaacs RJ, Davies SL, Sandri MI, Redwood C, Wells NJ and Hickson ID: Physiological regulation of eukaryotic topoisomerase II. Biochim Biophys Acta 1400: 121-137, 1998. (Pubitemid 28475099)
31. Wetzels RH, Schaafsma HE, Leigh IM, Lane EB, Troyanovsky SM, Wagenaar SS, Vooijs GP and Ramaekers FC: Laminin and type VII collagen distribution in different types of human lung carcinoma: correlation with expression of keratins 14, 16, 17 and 18. Histopathology 20: 295-303, 1992.
32. Yamada T, Endo R, Tsukagoshi K, Fujita S, Honda K, Kinoshita M, Hasebe T and Hirohashi S: Abberant expression of a hemidesmosomal protein, bullous pemphigoid antigen, in human squamous cell carcinoma. Lab Invest 75: 589-600, 1996. (Pubitemid 26346808)
33. Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA and Franklin WA: Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res 62: 3971-3979, 2002. (Pubitemid 34791062)
34. Nuber UAL: Expression der Gene der Desmocollin-Familie in menschlichen Zellen und Geweben. Dissertation A, Medizinsche Fakultät, Heidelberg, 1999.
35. Hofmann HS, Hansen G, Burdach S, Bartling B, Silber RE and Simm A: Discrimination of human lung neoplasm from normal lung by two target genes. Am J Respir Crit Care Med 170: 516-519, 2004. (Pubitemid 39209133)
36. Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Richards WG, Jaklitsch MT, Sugarbaker DJ and Bueno R: Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst 95: 598-605, 2003. (Pubitemid 36553506)
37. Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Ramaswamy S, Richards WG, Sugarbaker DJ and Bueno R: Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 62: 4963-4967, 2002. (Pubitemid 34984420)
38. Bueno R, Loughlin KR, Powell MH and Gordon GJ: A diagnostic test for prostate cancer from gene expression profiling data. J Urol 171: 903-906, 2004. (Pubitemid 38090530)
39. Hofmann HS, Hansen G, Richter G, Taege C, Simm A, Silber RE and Burdach S: Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res 11: 1086-1092, 2005. (Pubitemid 40175757)
40. Miyake M, Adachi M, Huang C, Higashiyama M, Kodama K and Taki T: A novel molecular staging protocol for non-small cell lung cancer. Oncogene 18: 2397-2404, 1999. (Pubitemid 29192718)
41. Kobayashi H, Gotoh J, Shinohara H, Moniwa N and Terao T: Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model. Thromb Haemost 71: 474-480, 1994. (Pubitemid 24100674)
42. Jankun J, Keck RW, Skrzypczak-Jankun E and Swiercz R: Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice. Cancer Res 57: 559-563, 1997. (Pubitemid 27085630)
43. Evans DM, Sloan-Stakleff K, Arvan M and Guyton DP: Time and dose dependency of the suppression of pulmonary metastases of rat mammary cancer by amiloride. Clin Exp Metastasis 16: 353-357, 1998. (Pubitemid 28255530)
44. Hofmann HS and Bartling B: How will lung cancer be treated in the future? Future Oncol 1: 551-559, 2005.